The Pharma Data

MARCH 7, 2022

The facility, expected to be operational by 2025, will support the growing demand for Amgen’s medicines that treat serious illnesses such as cancer and heart disease. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Science 52

Science Disease Research 52

The Pharma Data

SEPTEMBER 27, 2021

Across the world , Lilly employees work to get and convey life-changing medicines to those that need them, improve the understanding and management of disease, and provides back to communities through philanthropy and volunteerism. Source link: [link].

Marketing 40

Marketing Disease 40

The Pharma Data

JANUARY 25, 2021

This activity could increase (or reduce the size of any decrease in) the market price of the Company’s common stock, the notes or the Company’s 2.50% Convertible Senior Notes due 2027 at that time. BridgeBio’s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.

Marketing 52

Marketing Disease Clinical Trials Clinical Development 52

The Pharma Data

FEBRUARY 18, 2022

” Amgen’s four ESG pillars – Healthy People, Healthy Society, Healthy Planet, and a Healthy Amgen – include commitments to: Achieve carbon neutrality by 2027, along with a 40% reduction in water used and a 75% reduction in waste disposed.

Government 40

Government Clinical Trials Science Trials 40

Vial

DECEMBER 7, 2023

billion by 2027 , at a compound annual growth rate (CAGR) of 45.7% The main goal of this process is to identify potential drug candidates that can effectively treat diseases and improve health outcomes. The process begins with the identification of a biological target, such as a protein or a gene, that is implicated in a disease.

Drugs 52

Drugs Clinical Trials Trials Treatment 52

Agency IQ

FEBRUARY 2, 2024

BY LAURA DIANGELO, MPH | JAN 30, 2024 10:25 AM CST Diagnostic regulation: A quick overview Diagnostics products are those intended to identify, signal or detect a specific health condition, infection or disease, or monitor a person’s health or health status. In-house tests (similar to LDTs in the U.S.,

FDA 40

FDA Laboratories Regulations Production 40

Agency IQ

NOVEMBER 3, 2023

This has allowed them instead to be developed and run primarily under oversight from other agencies – including the Centers for Disease Control and Prevention (CDC) and Center for Medicare and Medicaid Services (CMS) – under a policy known as the Clinical Laboratory Improvement Amendments (CLIA).

FDA 40

FDA Laboratories Regulations Production 40

Agency IQ

AUGUST 18, 2023

The remaining seven categories should be covered by the eight labs – hepatitis and retrovirus, herpesviruses, arboviruses, respiratory viruses that cause life-threatening diseases, parasites, and blood grouping tests. It’s not clear what happened to the original 30 laboratories that the Member States identified as candidates.

Science 40

Science Regulations Laboratories Production 40

Agency IQ

FEBRUARY 21, 2024

Sponsors claimed that if TGA’s process was closer aligned to those of the FDA and EMA, they would submit applications for rare disease products much sooner, reducing current disparities in treatment availability for patients in Australia compared to those jurisdictions.

Science 40

Science Regulations International FDA 40

Drug Target Review

JUNE 5, 2023

Differentiated treatment options are needed, as cancer is a diverse disease that varies across and within organs due to many factors such as genetics, epigenetic influence as well as treatments (lines & type therapy). No single therapeutic mode has cured all cancers, so diversification in research and treatment is warranted.

Treatment 100

Treatment Pharmacokinetics Drugs Cell Biology 100

Agency IQ

FEBRUARY 15, 2024

If you’re looking for something specific, we recommend using the search function in your browser (Ctrl-F) to look for keywords of interest.

FDA 40

FDA Science Biosimilars Clinical Trials 40

Agency IQ

AUGUST 2, 2024

For example, on July 25, the Hungarian presidency hosted an informal meeting of health ministers to discuss health issues, such as mitigating the effect of cardiovascular diseases and implementing the European Health Data Space (EHDS). For implementing acts, the Commission is required to consult with a committee before adoption.

Regulations 40

Regulations Clinical Trials Production Trials 40

Agency IQ

JULY 28, 2023

September 2023 Legislative deadlines in Q3 Legislation Program Tag Requirement Due Date FDORA, Section 3202 Orphan Drug Program FDA shall publish final guidance related to the draft guidance titled, “Rare Diseases: Common Issues in Drug Development.”

FDA 40

FDA Science Biosimilars Regulations 40

The Pharma Data

FEBRUARY 8, 2021

RE47,739 (‘739) by more than four years until March 5, 2027. Severe, life-threatening, or fatal interstitial lung disease (ILD) and/or pneumonitis can occur in patients treated with CDK4/6 inhibitors, including IBRANCE when taken in combination with endocrine therapy. The certificate extends the term of U.S. 2,3 In the U.S.,

Clinical Trials 52

Clinical Trials Treatment Therapies Production 52

Agency IQ

JULY 5, 2023

See Asbestos Disease Awareness Organization v. Reported information would be used by EPA and other Federal agencies in considering the regulation of asbestos. This rulemaking is the result of a settlement agreement, stemming from litigation pursuant to TSCA section 21. 19-CV-00871; State of California et al. 19-CV-03807.

Regulations 40

Regulations Compliance International Engineering 40

The Pharma Data

DECEMBER 30, 2020

This week, Bloomberg reported companies agreed to slash the prices of 119 new therapies that treat a range of illnesses, including pulmonary disease, lupus, diabetes and cancer. billion by 2027. The company’s product candidate is targeting the global metastatic cancer treatment market, projected to be worth $111.2

Immune Response 52

Immune Response Vaccine Clinical Trials Treatment 52

Codon

OCTOBER 6, 2024

The disruptive biotech company Colossal Biosciences is best known for its headline-grabbing “de-extinction” project, with the stated goal of creating a living woolly mammoth by 2027.

FDA 121

FDA Hospitals Engineering Research 121

Agency IQ

JUNE 16, 2023

See Asbestos Disease Awareness Organization v. The standards would begin with model year 2027 heavy-duty vehicles, with stringency levels through model year 2030 and beyond. The standards will begin with model year 2027 light-duty vehicles, with stringency levels set at least through model year 2030. 19-CV-03807.

Regulations 40

Regulations Compliance Production Science 40

The Pharma Data

APRIL 7, 2021

Thirty of Sanofi’s medicines will be provided across a wide range of therapeutic areas, including cardiovascular disease, diabetes, tuberculosis, malaria and cancer. In December 2020, Sanofi announced it had renewed its five-year partnership with WHO to fight neglected tropical diseases that affect approximately one billion people.

Vaccine 52

Vaccine Packaging Disease Treatment 52

Drug Target Review

MARCH 20, 2025

Its one of the most common heart rhythm disorders and can be caused by conditions like high blood pressure and heart disease, or can sometimes occur without an obvious cause. These studies, anticipated to complete in 2027, could open doors for abelacimab’s approval in this indication.

Therapies 52

Therapies Clinical Development Trials FDA 52

The Pharma Data

MAY 4, 2021

Rare Disease. RE47,739 for Ibrance by more than four years until March 2027. In March 2021, Pfizer, the Israel Ministry of Health (MoH) and BioNTech announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with BNT162b2. Internal Medicine. Total Revenue.

Vaccine 40

Vaccine Production FDA Clinical Trials 40

FDA Law Blog: Biosimilars

JANUARY 29, 2025

With oversight over FDA, the Centers for Medicare & Medicaid Services, the National Institutes of Health, and the Centers for Disease Control and Prevention, Kennedys portfolio will be vast. Will he wait until the next PDUFA reauthorization in 2027 to instill additional changes at the agency? Kennedy, Jr.

FDA 59

FDA Vaccine Disease Drugs 59